|
| | HR0062 | | LRB100 07360 MST 17424 r |
|
|
| 1 | | HOUSE RESOLUTION
|
| 2 | | WHEREAS, Lymphedema is swelling that occurs in the arms and |
| 3 | | legs of an individual, often
caused by the removal of, or |
| 4 | | damage to, lymph nodes as part of a cancer treatment or other
|
| 5 | | infection; and
|
| 6 | | WHEREAS, The factors that increase the risk of lymphedema |
| 7 | | include cancer treatment, age,
excess weight or obesity, or |
| 8 | | rheumatoid or psoriatic arthritis; and
|
| 9 | | WHEREAS, Undiagnosed lymphedema can lead to serious |
| 10 | | complications, such as bacterial
infections of the skin and |
| 11 | | lymph vessels or lymphangiosarcoma, which is a rare form of |
| 12 | | soft tissue
cancer that results from severe cases of the |
| 13 | | disease; and
|
| 14 | | WHEREAS, Lymphedema cannot be cured, but the symptoms can |
| 15 | | be managed through a variety
of treatment options, such as |
| 16 | | exercise, massage, therapy, and compression garments; and
|
| 17 | | WHEREAS, The necessary compression garments and therapy |
| 18 | | treatment options can cost
between $200-$3,000 for a patient |
| 19 | | and are often not covered by insurance plans; and
|
| 20 | | WHEREAS, Lymphedema is not well-known and is often |